These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 16700816

  • 1. Effect of rifampicin on the pharmacokinetics of atenolol.
    Lilja JJ, Juntti-Patinen L, Neuvonen PJ.
    Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):555-8. PubMed ID: 16700816
    [Abstract] [Full Text] [Related]

  • 2. Effect of itraconazole on the pharmacokinetics of atenolol.
    Lilja JJ, Backman JT, Neuvonen PJ.
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):395-8. PubMed ID: 16364056
    [Abstract] [Full Text] [Related]

  • 3. Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol.
    Lilja JJ, Backman JT, Laitila J, Luurila H, Neuvonen PJ.
    Clin Pharmacol Ther; 2003 Mar; 73(3):192-8. PubMed ID: 12621384
    [Abstract] [Full Text] [Related]

  • 4. The effect of rifampin on the pharmacokinetics of oral and intravenous ondansetron.
    Villikka K, Kivistö KT, Neuvonen PJ.
    Clin Pharmacol Ther; 1999 Apr; 65(4):377-81. PubMed ID: 10223773
    [Abstract] [Full Text] [Related]

  • 5. Effects of orange juice on the pharmacokinetics of atenolol.
    Lilja JJ, Raaska K, Neuvonen PJ.
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):337-40. PubMed ID: 15983823
    [Abstract] [Full Text] [Related]

  • 6. Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects.
    Bolton AE, Peng B, Hubert M, Krebs-Brown A, Capdeville R, Keller U, Seiberling M.
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):102-6. PubMed ID: 14605865
    [Abstract] [Full Text] [Related]

  • 7. Rifampicin reduces plasma concentrations of celiprolol.
    Lilja JJ, Niemi M, Neuvonen PJ.
    Eur J Clin Pharmacol; 2004 Jan; 59(11):819-24. PubMed ID: 14614579
    [Abstract] [Full Text] [Related]

  • 8. Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations.
    Kyrklund C, Backman JT, Kivistö KT, Neuvonen M, Laitila J, Neuvonen PJ.
    Clin Pharmacol Ther; 2000 Dec; 68(6):592-7. PubMed ID: 11180018
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazone.
    Niemi M, Backman JT, Neuvonen PJ.
    Clin Pharmacol Ther; 2004 Sep; 76(3):239-49. PubMed ID: 15371985
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic and pharmacodynamic interaction of nadolol with itraconazole, rifampicin and grapefruit juice in healthy volunteers.
    Misaka S, Miyazaki N, Yatabe MS, Ono T, Shikama Y, Fukushima T, Kimura J.
    J Clin Pharmacol; 2013 Jul; 53(7):738-45. PubMed ID: 23677858
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of atenolol enantiomers in 12 Chinese healthy men.
    Wang XM, Yu XY, Lin SG.
    Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):367-70. PubMed ID: 10452127
    [Abstract] [Full Text] [Related]

  • 15. Rifampin reduces plasma concentrations and effects of zolpidem.
    Villikka K, Kivistö KT, Luurila H, Neuvonen PJ.
    Clin Pharmacol Ther; 1997 Dec; 62(6):629-34. PubMed ID: 9433391
    [Abstract] [Full Text] [Related]

  • 16. Effect of rifampicin on the pharmacokinetics of pioglitazone.
    Jaakkola T, Backman JT, Neuvonen M, Laitila J, Neuvonen PJ.
    Br J Clin Pharmacol; 2006 Jan; 61(1):70-8. PubMed ID: 16390353
    [Abstract] [Full Text] [Related]

  • 17. Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
    Wójcicki J, Jaroszynska M, Droździk M, Pawlik A, Gawrońska-Szklarz B, Sterna R.
    Biopharm Drug Dispos; 2003 Jul; 24(5):211-8. PubMed ID: 12784321
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biopharmaceutical evaluation of oral tablet Atenolol (100 and 50 mg) on local population.
    Ali O, Obaid R, Saify ZS, Ahmed SW.
    Pak J Pharm Sci; 2005 Jan; 18(1):25-32. PubMed ID: 16431379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.